Acquisition Opportunity ClinOne is now part of uMotif after a 2024 acquisition, presenting a unified opportunity to cross-sell or upsell complementary patient engagement and consent management capabilities to an expanded customer base across sponsorships, CROs, and site networks.

Enterprise Potential With revenue in the low millions and a strategic shift under uMotif, there is potential for scaled contracts with large sponsors and CROs who require robust, integrated trial engagement platforms across 60 countries.

Platform Enhancements Recent platform enhancements in 2024 indicate ongoing product evolution; sales conversations can emphasize new features, faster deployment, API integrations, and cost-efficient scalability as differentiators for trials of varying sizes.

Healthcare Partnerships Past collaborations with UC San Diego and SPRIM PRO highlight a track record of partnering with research institutions and health-focused organizations, suggesting a path for expanding academic and patient-centric trial programs.

Global Reach Active use by sponsors, CROs, and site networks in 60 countries signals a broad geographic footprint ideal for multinational trials and for selling solutions that streamline global patient engagement and consent workflows.